Kyung Nam Pharm Co Ltd (053950) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.023x

Based on the latest financial reports, Kyung Nam Pharm Co Ltd (053950) has a cash flow conversion efficiency ratio of -0.023x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.84 Billion ≈ $-1.93 Million USD) by net assets (₩125.39 Billion ≈ $84.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 053950 net asset quality index to measure how much of total assets are equity-financed.

Kyung Nam Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Kyung Nam Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Kyung Nam Pharm Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Kyung Nam Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kyung Nam Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Bluebird Merchant Ventures Ltd LSE:BMV	0.000x
Ptt PCL STU:PTOG	0.046x
PTT Public Company Limited F:PTOG	0.055x
PTT Global Chemical Public Company Limited F:GCB	-0.057x
Global UAV Technologies Ltd STU:YAB2	0.001x
Bruush Oral Care Inc. NASDAQ:BRSHF	1.689x
PipeHawk plc LSE:PIP	0.022x
Sabien Technology Group Plc LSE:SNT	-0.634x

Annual Cash Flow Conversion Efficiency for Kyung Nam Pharm Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Kyung Nam Pharm Co Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Kyung Nam Pharm Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩108.30 Billion ≈ $73.39 Million	₩-1.68 Billion ≈ $-1.14 Million	-0.016x	-197.34%
2024-12-31	₩115.22 Billion ≈ $78.09 Million	₩1.84 Billion ≈ $1.25 Million	0.016x	+106.72%
2023-12-31	₩89.83 Billion ≈ $60.88 Million	₩693.30 Million ≈ $469.84K	0.008x	+911.06%
2022-12-31	₩93.77 Billion ≈ $63.55 Million	₩71.58 Million ≈ $48.51K	0.001x	-98.33%
2020-12-31	₩57.36 Billion ≈ $38.87 Million	₩2.62 Billion ≈ $1.77 Million	0.046x	+143.42%
2019-12-31	₩61.19 Billion ≈ $41.47 Million	₩-6.43 Billion ≈ $-4.35 Million	-0.105x	-73.03%
2018-12-31	₩28.91 Billion ≈ $19.59 Million	₩-1.75 Billion ≈ $-1.19 Million	-0.061x	-120.88%
2016-12-31	₩16.82 Billion ≈ $11.40 Million	₩4.89 Billion ≈ $3.31 Million	0.291x	+1223.07%
2010-12-31	₩21.97 Billion ≈ $14.89 Million	₩482.65 Million ≈ $327.08K	0.022x	+119.25%
2007-12-31	₩14.85 Billion ≈ $10.06 Million	₩148.79 Million ≈ $100.84K	0.010x	--

About Kyung Nam Pharm Co Ltd

KQ:053950 Korea

Market Cap

$10.26K

₩15.14 Million KRW

Market Cap Rank

#31678 Global

#2121 in Korea

Share Price

₩1678.00

Change (1 day)

+4.68%

52-Week Range

₩1471.00 - ₩1678.00

All Time High

₩1678.00